Stay updated on Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.

Latest updates to the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference4%

- Check26 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check41 days agoChange DetectedUpdated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' link was removed, with no evident changes to core page content.SummaryDifference0.2%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check55 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific facility names and locations, while also removing previous location terms and related topics. Notably, the term 'IgA glomerulonephritis' has replaced 'IgA Nephropathy'.SummaryDifference4%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Efficacy Safety in Primary IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety in Primary IgA Nephropathy Clinical Trial page.